Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.010
-0.070 (-3.37%)
At close: Feb 27, 2026, 4:00 PM EST
1.970
-0.040 (-1.99%)
After-hours: Feb 27, 2026, 6:57 PM EST
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $7.65 million as of February 27, 2026. Its market cap has increased by 29.14% in one year.
Market Cap
7.65M
Enterprise Value
3.20M
1-Year Change
29.14%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $7.65M, a decrease of -99.33%. That is a compound annual growth rate of -65.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 7.65M | 10.53% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 7.96M |
| GridAI Technologies | 7.73M |
| Ernexa Therapeutics | 7.72M |
| Kiora Pharmaceuticals | 7.67M |
| Evogene | 7.44M |
| CalciMedica | 7.44M |
| Mustang Bio | 7.37M |
| Moleculin Biotech | 7.36M |